Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChrysalis Inves Regulatory News (CHRY)

Share Price Information for Chrysalis Inves (CHRY)

Share Price is delayed by 15 minutes
Get Live Data
76.70    0.00 (0.00%)
Bid:
0.00
Ask:
130.00
Spread: 53.30 (69.492%)
Market Cap: £368.91m
CHRY Live PriceLast checked at - London Stock Exchange

Intraday Chrysalis Inves Share Chart

Director Resignation

31 Dec 2025 07:01

RNS Number : 1983N
Chrysalis Investments Limited
31 December 2025
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than to professional investors in Belgium, Denmark, the Republic of Ireland, Luxembourg, the Netherlands, Norway and Sweden), Canada, Australia, Japan or the Republic of South Africa.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 which forms part of domestic law in the United Kingdom pursuant to The European Union Withdrawal Act 2018, as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019.

 

31 December 2025

 

 

Chrysalis Investments Limited ("Chrysalis" or the "Company")

 

Director Resignation

 

Chrysalis announces that further to the Chairman's statement in the 30 September 2025 audited financial statements, Mrs Anne Ewing, a non-executive Director of the Company, has expressed her desire to step down from the Board of Directors for personal reasons with effect from today.

The Board wish to express their gratitude to Mrs Ewing for all her hard work and valued contribution to the Company during her tenure.

 

 

-ENDS-

 

 

 

For further information, please contact

 

Media

Montfort Communications:

Charlotte McMullen / Imogen Saunders

 

 

 

+44 (0) 7826547304

chrysalis@montfort.london

 

 

Investment Adviser

Chrysalis Investment Partners LLP:

James Simpson

 

 

+44 (0) 20 7871 5343

G10 Capital Limited (AIFM):

+44 (0) 20 7397 5450

Maria Baldwin

 

 

 

Panmure Liberum:

Chris Clarke / Darren Vickers

 

+44 (0) 20 3100 2222

Deutsche Numis:

Nathan Brown / Matt Goss

+44 (0) 20 7260 1000

 

 

Barclays Bank PLC:

Dion Di Miceli / Stuart Muress / James Atkinson

 

 

+44 (0) 20 7623 2323

 

IQEQ Fund Services (Guernsey) Limited:

Aimee Gontier / Elaine Smeja

+44 (0) 1481 231852

 

LEI: 213800F9SQ753JQHSW24

A copy of this announcement will be available on the Company's website at https://www.chrysalisinvestments.co.uk

The information contained in this announcement regarding the Company's investments has been provided by the relevant underlying portfolio company and has not been independently verified by the Company. The information contained herein is unaudited.

This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

The Company is an alternative investment fund ("AIF") for the purposes of the AIFM Directive and as such is required to have an investment manager who is duly authorised to undertake the role of an alternative investment fund manager ("AIFM"). The AIFM appointed is G10 Capital Limited (part of the IQEQ Group).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATMBRTMTMJBLA
Date   Source Headline
7th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 20247:00 amRNSTransaction in Own Shares
31st Oct 20247:00 amRNSTransaction in Own Shares
30th Oct 20247:00 amRNSTransaction in Own Shares
29th Oct 20247:00 amRNSTransaction in Own Shares
28th Oct 20247:00 amRNSQuarterly NAV Announcement and Trading Update
28th Oct 20247:00 amRNSTransaction in Own Shares
25th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSTransaction in Own Shares
23rd Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 20247:00 amRNSTransaction in Own Shares
18th Oct 20247:00 amRNSTransaction in Own Shares
17th Oct 20247:00 amRNSTransaction in Own Shares
16th Oct 20247:00 amRNSTransaction in Own Shares
15th Oct 20247:00 amRNSTransaction in Own Shares
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20247:00 amRNSTransaction in Own Shares
10th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 20249:02 amRNSTransaction in Own Shares
8th Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20246:00 pmRNSAscential
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSTransaction in Own Shares
2nd Oct 20247:00 amRNSTransaction in Own Shares
1st Oct 202412:37 pmRNSTransaction in Own Shares
26th Sep 20242:14 pmRNSCommencement of Share Buyback Programme
26th Sep 20242:09 pmRNSDisposal and Portfolio Update
25th Sep 20247:00 amRNSDebt Facility
28th Aug 20241:11 pmRNSHolding(s) in Company
16th Aug 20241:26 pmRNSHolding(s) in Company
12th Aug 202412:00 pmRNSChange of Administrator and Registered Office
29th Jul 202412:30 pmRNSQuarterly NAV Announcement and Trading Update
12th Jul 20248:00 amRNSHolding(s) in Company
12th Jul 20247:00 amRNSDisposal and Liquidity Update
28th Jun 20242:30 pmRNSInterim Results
5th Jun 202412:00 pmRNSHolding(s) in Company
17th May 20247:00 amRNSPortfolio Update
2nd May 20247:00 amRNSQuarterly NAV Announcement and Trading Update
22nd Apr 20247:43 amRNSUpdate on claim against Revolution Beauty GroupPLC
15th Mar 20243:05 pmRNSResult of AGM & EGM
14th Mar 202412:28 pmRNSHolding(s) in Company
13th Mar 202411:36 amRNSHolding(s) in Company
11th Mar 20243:21 pmRNSHolding(s) in Company
7th Mar 20247:00 amRNSPortfolio Update
1st Mar 20243:01 pmRNSHolding(s) in Company
29th Feb 20249:48 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.